Résultats de recherche

10 results found

…   Discuss basic concepts and methods for inactivation of pathogens in blood products. 2.    Review literature on … clinical performance of PRT treated products. 3.    Discuss pathogen reduction performance levels and clinical outcomes … 2.    Estcourt LJ, Malouf R, Hopewell S, et al. Pathogen-reduced platelets for the prevention of bleeding. Cochrane …
7 septembre 2023
… associations (WHO, WFH, IPOPI, IPFA, PPTA) and suppliers of pathogen reduction technologies & plasma processing devices … therapeutic plasma proteins: quarantine/retested plasma; pathogen-reduced plasma, cryo-poor plasma, and …
7 septembre 2023
… . To improve blood safety, many countries have implemented pathogen inactivation technologies to reduce the risk of … 2021, Health Canada approved the use of Cerus INTERCEPT Pathogen Inactivation Technology (PIT) for manufacturing … stem cell transplant patients who received pathogen-reduced platelets that were both not irradiated nor …
13 septembre 2024
… from Dr. Michelle Zeller of McMaster University on pathogen-reduced platelets, Dr. Andrew Petrosoniak of Sunnybrook …
16 mars 2023
… from Dr. Michelle Zeller of McMaster University on pathogen-reduced platelets, Dr. Andrew Petrosoniak of Sunnybrook …
16 mars 2023
… on Canadian Blood Services platelet bacterial screening . Pathogen inactivation adds an extra layer of protection against a number of pathogens, including bacteria and viruses. By effectively … transmission. See Chapter 19 for more about pathogen-reduced platelets.   Dyspnea Dyspnea or hypoxemia can occur …
17 juin 2024
… . Lu W, Fung M. Platelets Treated with Pathogen Reduction Technology: Current Status and Future … . Devine DV, Schubert P. Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk. …
25 juillet 2024
15 juillet 2024